Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Allient (ALNT) Research & Development (2016 - 2026)

Allient has reported Research & Development over the past 16 years, most recently at $9.7 million for Q4 2025.

  • Quarterly Research & Development rose 3.27% to $9.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $38.8 million through Dec 2025, down 2.33% year-over-year, with the annual reading at $38.8 million for FY2025, 2.33% down from the prior year.
  • Research & Development was $9.7 million for Q4 2025 at Allient, roughly flat from $9.7 million in the prior quarter.
  • Over five years, Research & Development peaked at $11.1 million in Q1 2024 and troughed at $94000.0 in Q3 2021.
  • The 5-year median for Research & Development is $9.6 million (2025), against an average of $7.0 million.
  • Year-over-year, Research & Development crashed 98.54% in 2021 and then soared 5277.89% in 2023.
  • A 5-year view of Research & Development shows it stood at $1.0 million in 2021, then surged by 839.09% to $9.7 million in 2022, then rose by 9.73% to $10.6 million in 2023, then decreased by 12.04% to $9.3 million in 2024, then increased by 3.27% to $9.7 million in 2025.
  • Per Business Quant, the three most recent readings for ALNT's Research & Development are $9.7 million (Q4 2025), $9.7 million (Q3 2025), and $9.9 million (Q2 2025).